Lexaria Bioscience (LEXXW) Short Interest Ratio & Short Volume $0.17 -0.01 (-4.29%) As of 03:54 PM Eastern Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock Lexaria Bioscience Short Interest DataLexaria Bioscience (LEXXW) has a short interest of 4,000 shares. This marks a -31.03% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.4, indicating that it would take 0.4 days of the average trading volume of 10,730 shares to cover all short positions.Current Short Interest4,000 sharesPrevious Short Interest5,800 sharesChange Vs. Previous Month-31.03%Dollar Volume Sold Short$1,206.80Short Interest Ratio0.4 Days to CoverLast Record DateApril 30, 2025Today's Trading Volume1,043 sharesAverage Trading Volume10,730 sharesToday's Volume Vs. Average10% Short Selling Lexaria Bioscience? Sign up to receive the latest short interest report for Lexaria Bioscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartLEXXW Short Interest Over TimeLEXXW Days to Cover Over TimeLEXXW Percentage of Float Shorted Over Time Lexaria Bioscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20254,000 shares $1,206.80 -31.0%N/A0.4 $0.30 4/15/20255,800 shares $2,146.58 -3.3%N/A0.6 $0.37 3/31/20256,000 shares $2,261.40 +150.0%N/A0.6 $0.38 3/15/20252,400 shares $623.28 +20.0%N/A0.2 $0.26 2/28/20252,000 shares $498.00 -41.2%N/A0.2 $0.25 2/15/20253,400 shares $1,156.00 +3.0%N/A0.3 $0.34 1/31/20253,300 shares $1,257.30 +73.7%N/A0.5 $0.38 1/15/20251,900 shares $1,329.81 -70.3%N/A0.4 $0.70 12/31/20246,400 shares $4,890.24 -21.0%N/A1.2 $0.76 12/15/20248,100 shares $6,318.00 +161.3%N/A1.3 $0.78 Get the Latest News and Ratings for LEXXW and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lexaria Bioscience and its competitors with MarketBeat's FREE daily newsletter. 11/30/20243,100 shares $2,480.00 -8.8%N/A0.3 $0.80 11/15/20243,400 shares $2,074.00 +30.8%N/A0.3 $0.61 10/31/20242,600 shares $1,820.00 -49.0%N/A0.2 $0.70 10/15/20245,100 shares $3,886.20 +41.7%N/A0.4 $0.76 9/30/20243,600 shares $3,308.40 -68.7%N/A0.3 $0.92 9/15/202411,500 shares $11,500.00 +202.6%N/A0.9 $1.00 8/31/20243,800 shares $5,320.00 +46.2%N/A0.5 $1.40 8/15/20242,600 shares $3,900.00 +766.7%N/A0.4 $1.50 7/31/2024300 shares $336.00 -62.5%N/A0 $1.12 7/15/2024800 shares $800.00 +700.0%N/A0.1 $1.00 6/30/2024100 shares $80.63 No ChangeN/A0 $0.81 6/15/2024100 shares $138.00 -98.2%N/A0 $1.38 5/31/20245,400 shares $8,046.00 +92.9%N/A0.3 $1.49 5/15/20242,800 shares $3,780.00 -36.4%N/A0.1 $1.35 4/30/20244,400 shares $4,319.04 -74.4%N/A0.2 $0.98 4/15/202417,200 shares $12,038.28 -23.6%N/A1.4 $0.70 3/31/202422,500 shares $33,750.00 +4.2%N/A1.9 $1.50 3/15/202421,600 shares $22,248.00 +14.3%N/A1.8 $1.03 2/29/202418,900 shares $15,120.00 -33.9%N/A1.8 $0.80 2/15/202428,600 shares $24,024.00 +9.2%N/A3.9 $0.84 1/31/202426,200 shares $12,080.82 No ChangeN/A3.4 $0.46 12/30/2022900 shares $359.91 No ChangeN/A0.2 $0.40 12/15/2022900 shares $414.00 +12.5%N/A0.2 $0.46 11/30/2022800 shares $456.00 +14.3%N/A0.1 $0.57 11/15/2022700 shares $406.00 +16.7%N/A0.1 $0.58 10/31/2022600 shares $360.00 -93.8%N/A0.1 $0.60 10/15/20229,600 shares $4,599.36 +9.1%N/A1.8 $0.48 9/30/20228,800 shares $5,192.00 +877.8%N/A2.1 $0.59 9/15/2022900 shares $729.00 +28.6%N/A0.2 $0.81 8/31/2022700 shares $518.07 +16.7%N/A0.3 $0.74Trump Exec Order 14179 is wealth “gift” to good Americans? (Ad)Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is 8/15/2022600 shares $498.06 +50.0%N/A0.2 $0.83 7/31/2022400 shares $260.28 +100.0%N/A0.2 $0.65 7/15/2022200 shares $180.02 No ChangeN/A0.1 $0.90 LEXXW Short Interest - Frequently Asked Questions What is Lexaria Bioscience's current short interest? Short interest is the volume of Lexaria Bioscience shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 4,000 shares of LEXXW short. Learn More on Lexaria Bioscience's current short interest. Is Lexaria Bioscience's short interest increasing or decreasing? Lexaria Bioscience saw a decrease in short interest in April. As of April 30th, there was short interest totaling 4,000 shares, a decrease of 31.0% from the previous total of 5,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Lexaria Bioscience stock? Short selling LEXXW is an investing strategy that aims to generate trading profit from Lexaria Bioscience as its price is falling. LEXXW shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Lexaria Bioscience? A short squeeze for Lexaria Bioscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of LEXXW, which in turn drives the price of the stock up even further. How often is Lexaria Bioscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LEXXW, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies ALVOW Short Squeeze BCTXW Short Squeeze CLNNW Short Squeeze ENGNW Short Squeeze FBIOP Short Squeeze IMTXW Short Squeeze JSPRW Short Squeeze LIXTW Short Squeeze NLSPW Short Squeeze NRXPW Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:LEXXW) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lexaria Bioscience Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lexaria Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LEXXW Stock Free LEXXW Stock Alerts